Novel fluorosurfactants for perfluorochemical emulsification: Effects on aggregation of human platelets in vitro and possible applications as anti-thrombotic agents

Advances in Experimental Medicine and Biology

Volumn 428, Issue , 1997, Pages 489-493

  Edwards, C M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PERFLUORO COMPOUND; SURFACTANT; FIBRINOLYTIC AGENT; FLUOROCARBON; POLOXAMER;

ANTICOAGULATION; CONFERENCE PAPER; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; EMULSION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; ERYTHROCYTE AGGREGATION; IN VITRO STUDY; PHYSIOLOGY; THROMBOCYTE;

BLOOD PLATELETS; ERYTHROCYTE AGGREGATION; FIBRINOLYTIC AGENTS; FLUOROCARBONS; HUMANS; MOLECULAR STRUCTURE; POLOXALENE; SURFACE-ACTIVE AGENTS;

EID: 0031310555     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5399-1_69     Document Type: Article

References (4)

1. Edwards, C.M., Heptinstall, S., and Lowe, K.C. Inhibitory effects of the co-polymer surfactant, Pluronic F-68, on spontaneous platelet aggregation in human whole blood. Br. J. Pharmacol. 116, 159P (1995).
2. Edwards, C.M., May, J.A. Heptinstall, S., and Lowe, K.C. Effects of Pluronic® F-68 (Poloxamer 188) on platelet aggregation in human whole blood. Thromb. Res. 81, 511-512 (1996).
3. 2) to inhibit platelet-aggregation and to prevent restenosis after coronary angioplasty. Results of a randomised placebo-controlled trial. Br. Heart J. 71, 7-15(1995).
4. Jouani, M.A., Szonyi, F., Trabelsi, H., and Cambon, A. Synthèse de tensioactifs non ioniques F-alkylés polyhydroxylés. Bull. Soc. Chim. Fr. 131, 173-176 (1994).